ليست عنوان مقالات لاتين Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article Cardiovascular disease

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article

2

Cardiac performance early after cardioversion from atrial fibrillation, , , , ,

3

CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

4

Cardiac performance is reduced following high-fat diet

5

Cardiac Performance Measure Compliance in Outpatients: The American College of Cardiology and National Cardiovascular Data Registryʹs PINNACLE (Practice Innovation And Clinical Excellence) Program

6

Cardiac phenotypes in relaxin knockout mice: Importance of the gender

7

Cardiac pheochromocytoma

8

Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan

9

Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis

10

Cardiac Physical Diagnosis in the Digital Age: An Important but Increasingly Neglected Skill (from Stethoscopes to Microchips)

11

Cardiac plasmacytoma

12

Cardiac Positron Emission Tomography

13

Cardiac positron emission tomography and the role of adenosine pharmacologic stress

14

Cardiac Positron Emission Tomography as a Prognostic Indicator of Cardiac Sarcoidosis

15

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

16

Cardiac positron emission tomography imaging with [11c]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

17

Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy

18

Cardiac potassium channel dysfunction in sudden infant death syndrome

19

Cardiac potassium currents and channels: Part II: Implications for clinical practice and therapy

20

Cardiac potassium currents and channels-Part I: Basic science aspects

21

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry Original Research Article

22

Cardiac Power Output during Dobutamine Stress Test in Horses

23

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

24

Cardiac problems related to burns and/or burn treatment

25

Cardiac procedure use following acute myocardial infarction among American Indians

26

Cardiac Procedures in Lung Transplant Recipients Do Not Increase Mortality in Selected Patients

27

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

28

Cardiac progenitor cells application in cardiovascular disease

29

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

30

Cardiac protection: Evolving role of angiotensin receptor blockers

31

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

32

Cardiac pulsations in patients with isolated right ventricular infarction

33

Cardiac Regeneration Review Article

34

Cardiac Rehab: Bridging the Transition from Hospital to Home

35

Cardiac rehabilitation

36

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

37

Cardiac rehabilitation and depression

38

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

39

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

40

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

41

Cardiac Rehabilitation and Survival in Older Coronary Patients

42

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

43

Cardiac Rehabilitation Following Myocardial Infarction

44

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

45

Cardiac rehabilitation I: review of psychosocial factors

46

Cardiac rehabilitation II: referral and participation

47

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

48

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

49

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

50

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

51

Cardiac rehabilitation in the elderly

52

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

53

Cardiac rehabilitation services in England and Wales: a national survey

54

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

55

Cardiac Rehabilitation, Exercise Training, and Anxiety

56

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

57

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

58

Cardiac rehabilitation: A review of current developments

59

Cardiac rehabilitation: How can it be improved?

60

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

61

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

62

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

63

Cardiac remodeling after long term norepinephrine treatment in rats

64

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

65

Cardiac remodeling and failure: From molecules to man (Part I)

66

Cardiac remodeling and failure: From molecules to man (Part II)

67

Cardiac remodeling and failure: From molecules to man (Part III)

68

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

69

Cardiac remodeling in coronary artery disease

70

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

71

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

72

Cardiac remodeling: is 8 the heart’s lucky number?

73

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

74

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

75

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

76

Cardiac reoperation in the intensive care unit

77

Cardiac reoperations in octogenarians: analysis of outcomes

78

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

79

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

80

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

81

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

82

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

83

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

84

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

85

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

86

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

87

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

88

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

89

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

90

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

91

Cardiac resynchronisation – a new standard in heart failure therapy

92

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

93

Cardiac Resynchronisation Therapy in Heart Failure

94

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

95

Cardiac resynchronization by pacing: an electrical treatment of heart failure

96

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

97

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

98

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

99

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

100

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

101

Cardiac Resynchronization Therapy

102

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

103

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

104

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

105

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

106

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

107

Cardiac Resynchronization Therapy for the Failing Fontan Patient

108

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

109

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

110

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

111

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

112

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

113

Cardiac resynchronization therapy in congenital heart disease

114

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

115

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

116

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

117

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

118

Cardiac resynchronization therapy in patients with narrow QRS

119

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

120

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

121

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

122

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

123

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

124

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

125

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

126

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

127

Cardiac resynchronization therapy upregulates cardiac autonomic control

128

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

129

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

130

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

131

Cardiac resynchronization therapy: A regulatory perspective

132

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

133

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

134

Cardiac resynchronization therapy: caveat medicus! Review Article

135

Cardiac Resynchronization Therapy: Location Matters

136

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

137

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

138

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

139

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

140

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

141

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

142

Cardiac retransplantation in children

143

Cardiac rhabdomyoma

144

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

145

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

146

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

147

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

148

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

149

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

150

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

151

Cardiac risk factors

152

Cardiac risk factors

153

Cardiac risk for vascular surgery

154

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

155

Cardiac risk in pregnant women with rheumatic mitral stenosis

156

Cardiac risk management in severe mental illness

157

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

158

Cardiac risk stratification

159

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

160

Cardiac risk: Theme con variations

161

Cardiac rupture – experience-based cardiology

162

Cardiac Rupture After Catheter Ablation Procedure

163

Cardiac rupture and tamponade during ventriculography

164

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

165

Cardiac rupture complicating myocardial infarction

166

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

167

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

168

Cardiac Rupture During Vacuum-Assisted Closure Therapy

169

Cardiac rupture or pericardial effusion?

170

Cardiac Sarcoidosis

171

Cardiac Sarcoidosis

172

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

173

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

174

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

175

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

176

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

177

Cardiac Sca-1+ and side population cells in cardiac regeneration

178

Cardiac screening proposed for HIV-1-infected children

179

Cardiac sensitization: methodology and interpretation in risk assessment

180

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

181

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

182

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

183

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

184

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

185

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

186

Cardiac stabilizer for minimally invasive direct coronary artery bypass

187

Cardiac state diagnosis using adaptive neuro-fuzzy technique

188

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

189

Cardiac Steatosis and Myocardial Dysfunction

190

Cardiac Stem Cell Transplantation

191

Cardiac stem cells and myocardial disease

192

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

193

Cardiac stents: the next generation

194

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

195

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

196

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

197

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

198

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

199

Cardiac structure and function Review Article

200

Cardiac structure and function after short-term ethanol consumption in rats

201

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

202

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

203

Cardiac Structure and Function in Persons 85 Years of Age

204

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

205

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

206

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

207

Cardiac surgeons in England face publication of outcomes data

208

Cardiac surgery

209

Cardiac surgery and cold-reactive proteins

210

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

211

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

212

Cardiac surgery for octogenarians: is it an informed decision?

213

Cardiac surgery in a fixed-reimbursement environment

214

Cardiac surgery in African Americans

215

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

216

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

217

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

218

Cardiac surgery in octogenarians with poor lung function

219

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

220

Cardiac surgery in octogenarians: have we gone too far or not far enough?

221

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

222

Cardiac surgery in patients infected with the human immunodeficiency virus

223

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

224

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

225

Cardiac surgery in patients with end-stage renal disease: 10-year experience

226

Cardiac Surgery in Patients With Liver Cirrhosis

227

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

228

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

229

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

230

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

231

Cardiac surgery report cards: comprehensive review and statistical critique

232

Cardiac surgery report cards: making the grade

233

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

234

Cardiac Surgery Risk Models: A Position Article

235

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

236

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

237

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

238

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

239

Cardiac surgical implications of calcium dyshomeostasis in the heart

240

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

241

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

242

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

243

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

244

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

245

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

246

Cardiac sympathetic innervation and control of potassium channel function

247

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

248

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

249

Cardiac syndrome X versus metabolic syndrome X

250

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

251

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

252

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

253

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

254

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

255

Cardiac tamponade as a life-threatening complication in antireflux surgery

256

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

257

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

258

Cardiac tamponade as manifestation of advanced thymic carcinoma

259

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

260

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

261

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

262

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

263

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

264

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

265

Cardiac tamponade due to pneumopericardium

266

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

267

Cardiac tamponade during thoracic endovascular aortic repair

268

Cardiac tamponade following pacemaker implantation

269

Cardiac tamponade from central venous catheters

270

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

271

Cardiac tamponade in a neglected case of thyroid agenesis

272

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

273

Cardiac tamponade in acquired immunodeficiency syndrome

274

Cardiac tamponade in acute rheumatic fever

275

Cardiac tamponade in Hashimotoʹs disease

276

Cardiac tamponade in hereditary hemorrhagic telangiectasia

277

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

278

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

279

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

280

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

281

Cardiac tamponade without pericardial effusion after blunt chest trauma

282

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

283

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

284

Cardiac teratogenicity of trichloroethylene metabolites

285

Cardiac thromboemboli complicating a stab wound to the heart

286

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

287

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

288

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

289

Cardiac toxicity of sunitinib

290

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

291

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

292

Cardiac Transplant Following Failed Fontan or Glenn Procedures

293

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

294

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

295

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

296

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

297

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

298

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

299

Cardiac transplantation for the cardiologist not trained in transplantation

300

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

301

Cardiac transplantation in a patient with protein S deficiency

302

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

303

Cardiac Transplantation in Adults With Small Hearts

304

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

305

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

306

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

307

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

308

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

309

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

310

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

311

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

312

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

313

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

314

Cardiac troponin I

315

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

316

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

317

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

318

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

319

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

320

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

321

Cardiac troponin I as a marker for AMI

322

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

323

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

324

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

325

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

326

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

327

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

328

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

329

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

330

Cardiac troponin i in acute pericarditis

331

Cardiac troponin I in aortic valve disease

332

Cardiac troponin I in neonates undergoing the arterial switch operation

333

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

334

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

335

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

336

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

337

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

338

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

339

Cardiac troponin I proves less accurate in low-risk cardiac patients

340

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

341

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

342

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

343

Cardiac troponin I release in heart transplantation

344

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

345

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

346

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

347

Cardiac Troponin Increases Among Runners in the Boston Marathon

348

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

349

Cardiac troponin release in response to transient ST segment depression

350

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

351

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

352

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

353

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

354

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

355

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

356

Cardiac troponin T concentration after coronary balloon angioplasty

357

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

358

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

359

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

360

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

361

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

362

Cardiac troponin T levels in umbilical cord blood,

363

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

364

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

365

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

366

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

367

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

368

Cardiac troponin-I content of skeletal muscle in patients with renal failure

369

Cardiac troponins after a downhill marathon

370

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

371

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

372

Cardiac troponins in congestive heart failure, ,

373

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

374

Cardiac troponins in renal insufficiency: Review and clinical implications

375

Cardiac Troponins in Young Marathon Runners

376

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

377

Cardiac troponins: IT upgrade for the heart

378

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

379

Cardiac tuberculosis presenting as small intestinal gangrene

380

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

381

Cardiac tumor due to Erdheim-Chester disease

382

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

383

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

384

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

385

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

386

Cardiac Uses of Phosphodiesterase-5 Inhibitors

387

Cardiac vagal activity: a target for intervention in heart disease

388

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

389

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

390

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

391

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

392

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

393

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

394

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

395

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

396

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

397

Cardiac valve replacement in human immunodeficiency virus–infected patients

398

Cardiac valve replacement in patients on dialysis

399

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

400

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

401

Cardiac Valvular Calcification in Hemodialysis Patients

402

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

403

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

404

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

405

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

406

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

407

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

408

Cardiac Whipple’s disease without digestive symptoms

409

Cardiac Xenotransplantation

410

Cardiac xenotransplantation: clinical experience and future direction

411

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

412

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

413

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

414

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

415

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

416

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

417

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

418

Cardiac-specific Gene Expression: a HANDful of Factors

419

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

420

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

421

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

422

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

423

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

424

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

425

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

426

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

427

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

428

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

429

Cardinal B-spline dictionaries on a compact interval

430

Cardinal characteristics and projective wellorders

431

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

432

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

433

Cardinal characteristics for Menger-bounded subgroups

434

Cardinal directions between spatial objects: the pairwise-consistency problem

435

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

436

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

437

Cardinal functions of Pixley–Roy hyperspaces

438

Cardinal Interpolating Multiresolutions Original Research Article

439

Cardinal interpolation with polysplines on annuli Original Research Article

440

Cardinal invariants about shrinkability of unbounded sets

441

Cardinal invariants above the continuum Original Research Article

442

Cardinal invariants and -factorizability in paratopological groups

443

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

444

Cardinal invariants in locally -minimal paratopological groups

445

Cardinal invariants of monotonically normal spaces

446

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

447

Cardinal invariants related to permutation groups

448

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

449

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

450

Cardinal sequences

451

Cardinal sequences of LCS spaces under GCH

452

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

453

Cardinal temperatures for germination of Kochia scoparia (L.)

454

Cardinal transfer properties in extender models

455

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

456

Cardinalities in depth: a formal approach to partial validation of conceptual schema

457

Cardinalities of ccc-spaces with regular -diagonals

458

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

459

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

460

Cardinality and the borda score

461

Cardinality Approach to Fuzzy Number Arithmetic

462

Cardinality bounds for subdirectly irreducible algebras Original Research Article

463

Cardinality concepts for type-two fuzzy sets

464

Cardinality constrained Boolean quadratic polytope Original Research Article

465

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

466

Cardinality, quantifiers, and the aggregation of fuzzy criteria

467

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

468

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

469

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

470

Cardioactive steroid poisoning from an herbal cleansing preparation

471

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

472

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

473

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

474

Cardiocerebral Resuscitation for Cardiac Arrest

475

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

476

Cardiocerebral Resuscitation: A Broader Perspective

477

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

478

Cardio-cerebrovascular complications in elderly with diabetes

479

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

480

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

481

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

482

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

483

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

484

Cardioembolic Stroke

485

Cardioembolic stroke: an update

486

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

487

Cardio-facio-cutaneous syndrome and moyamoya syndrome

488

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

489

Cardiogenic and Aortogenic Brain Embolism Review Article

490

Cardiogenic shock

491

Cardiogenic shock

492

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

493

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

494

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

495

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

496

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

497

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

498

Cardiogenic shock complicating acute coronary syndromes

499

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

500

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

501

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

502

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

503

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

504

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

505

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

506

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

507

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

508

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

509

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

510

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

511

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

512

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

513

Cardiogenic shock: Basics and clinical considerations

514

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

515

Cardiogenic shock: is there light at the end of the tunnel?

516

Cardiographic conundrum: Adding insult to injury

517

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

518

Cardioinhibitory syncope due to bloodphobia associated asystole

519

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

520

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

521

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

522

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

523

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

524

Cardiological applications of nuclear medicine Review Article

525

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

526

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

527

Cardiologist in the carotids

528

Cardiologist in the dugout

529

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

530

Cardiologist on trial: reflections on credible evidence

531

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

532

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

533

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

534

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

535

Cardiologists in casualty?

536

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

537

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

538

Cardiologists recommend Fragmin

539

Cardiologists versus internists in the care of unstable angin

540

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

541

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

542

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

543

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

544

Cardiology and emergency medicine: United We Stand, divided we fall

545

Cardiology and neurologic family screening in noncompaction

546

Cardiology and the Critical Care Crisis: A Perspective Review Article

547

Cardiology in a Flat World

548

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

549

Cardiology in contemporary China: An update

550

Cardiology in India

551

Cardiology in India: State of the Art or Straight off the Heart?

552

Cardiology in South America

553

Cardiology Integration: Challenge and Opportunity

554

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

555

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

556

Cardiology rounds

557

Cardiology screening on the net

558

Cardiology Workforce Crisis: Shortage or Surplus?

559

Cardiology Workforce Revisited

560

Cardiology workforce: there’s already a shortage, and it’s getting worse!

561

Cardiology, for what itʹs worth

562

Cardiology: “Itʹs small world after all”

563

Cardiology: a call for papers

564

Cardiology: American Journal of Medicine theme issue

565

Cardiology: call for papers

566

Cardiology: the past, the present, and the future

567

Cardiology: where to go from here?

568

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

569

Cardiomegaly in a young infant

570

Cardiometabolic Abnormalities in Current National Football League Players

571

Cardiometabolic Consequences of Gestational Dysglycemia

572

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

573

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

574

Cardio-metabolic risk factors in Iranian children: where we are and the others?

575

Cardiometabolic risk factors in polycystic ovary syndrome

576

Cardiomodulating Activity of Gongronema latifolium and Lisinopril in Doxorubicin-induced Cardiotoxicity in Wistar Rats

577

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

578

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

579

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

580

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

581

Cardiomyocyte death and renewal in the normal and diseased heart

582

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

583

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

584

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

585

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

586

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

587

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

588

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

589

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

590

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

591

Cardiomyocyte Transplantation Improves Heart Function

592

Cardiomyocyte-restricted deletion of connexin43 during mouse development

593

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

594

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

595

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

596

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

597

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

598

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

599

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

600

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

601

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

602

Cardiomyopathic lentiginosis: an echo-Doppler report

603

Cardiomyopathies: from genetics to the prospect of treatment

604

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

605

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

606

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

607

Cardiomyopathy in a Male with Cystinosis

608

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

609

Cardiomyopathy in Danish patients with coeliac disease

610

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

611

Cardiomyopathy in neurological disorders

612

CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.

613

Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis

614

Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy

615

Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports

616

Cardiomyopathy, nephropathy, and death in a 44-year-old man

617

Cardiomyopathy: a role for nitric oxide?

618

Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)

619

Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator

620

Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression

621

Cardiomyoplasty: Is it time to wrap it up?

622

Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ

623

Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease

624

Cardio-Oncology in Iran: Cardio-toxicity Registry

625

Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus

626

Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding

627

Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

628

Cardioplegia in pediatric cardiac surgery: do we believe in magic?

629

Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts

630

Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum

631

Cardioplegia-induced cell swelling: prevention by normothermic infusion

632

Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial

633

Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?

634

Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells

635

Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics

636

Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy

637

Cardioprotection and garlic

638

Cardioprotection and garlic

639

Cardioprotection and garlic

640

Cardioprotection and garlic

641

Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury

642

Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism

643

Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

644

Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger

645

Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage

646

Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin

647

Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase

648

Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion

649

Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action

650

Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least

651

Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist

652

Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery

653

Cardioprotection for Duchenne’s muscular dystrophy, ,

654

Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN

655

Cardioprotection in aged myocardium: Sites of failure in protective signalling

656

Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult

657

Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor

658

Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects

659

Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy

660

Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes

661

Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart

662

Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease

663

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article

664

Cardio-protective and anti-cancer therapeutic potential of Nigella sativa

665

Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem

666

Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)

667

Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals

668

Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets

669

Cardioprotective and neuroprotective roles of oleuropein in olive

670

Cardioprotective and neuroprotective roles of oleuropein in olive

671

Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients

672

Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart

673

Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats

674

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase

675

Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification

676

Cardioprotective effect of chronic hypoxia is blunted by hypercapnia

677

Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning

678

Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting

679

Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart

680

Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats

681

Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial

682

Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration

683

Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion

684

Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways

685

Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats

686

Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats

687

Cardioprotective effect of growth hormone secretagogues in rat heart

688

Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)

689

Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats

690

Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats

691

Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion

692

Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion

693

Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels

694

Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study

695

Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats

696

Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats

697

Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system

698

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat

699

CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY

700

Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI

701

Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts

702

Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis

703

Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?

704

Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention

705

Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats

706

Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats

707

Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

708

Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study

709

Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat

710

Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats

711

Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours

712

Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure

713

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

714

Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article

715

Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury

716

Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism

717

Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins

718

cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure

719

Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart

720

cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice

721

Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury

722

Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart

723

Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia

724

Cardioprotective effects of preinfarction angina in elderly: same patients, different results?

725

Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats

726

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention

727

Cardioprotective effects of the NHE1-inhibitor EMD 87580

728

Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia

729

Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research

730

Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts

731

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article

732

Cardioprotective Potential of Antihypertensives

733

Cardioprotective potential of biobased gold nanoparticles

734

Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia

735

Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits

736

Cardio-protective properties of Momordica charantia in Albino Rats

737

Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats

738

Cardioprotective role of FGF2 in a murine model of low-flow ischemia

739

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model

740

Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals

741

Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery

742

Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran

743

CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL

744

CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA

745

Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting

746

Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery

747

Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation

748

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics

749

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans

750

Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility

751

Cardiopulmonary bypass during pregnancy

752

Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma

753

Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels

754

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant

755

Cardiopulmonary bypass in humans: bypassing unfractionated heparin

756

Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation

757

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis

758

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172

759

Cardiopulmonary bypass in pregnancy

760

Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases

761

Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function

762

Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension

763

Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans

764

Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow

765

Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia

766

Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia

767

Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation

768

Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions

769

Cardiopulmonary bypass, rewarming, and central nervous system dysfunction

770

Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit

771

Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital

772

Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys

773

Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves

774

Cardiopulmonary effects of HI-6 treatment in soman intoxication

775

Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys

776

Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome

777

Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure

778

Cardiopulmonary exercise test evidence of isolated right coronary artery disease

779

Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates

780

Cardiopulmonary exercise test in patients with subacute pulmonary emboli

781

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

782

Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension

783

Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation

784

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article

785

Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation

786

Cardiopulmonary exercise testing in patients with heart failure

787

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article

788

Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure

789

Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma

790

Cardiopulmonary function in adult patients late after Fontan repair

791

Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities

792

Cardiopulmonary hazards of perihepatic packing for major liver injuries,

793

Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain

794

Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application

795

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

796

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

797

Cardiopulmonary mortality and air pollution

798

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

799

Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review

800

Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome

801

Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure

802

Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis

803

Cardiopulmonary responses to robotic end-effector-based walking and stair climbing

804

Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects

805

CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA

806

Cardiopulmonary resuscitation and neurological complications in the elderly

807

Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study

808

Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance

809

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study

810

Cardiopulmonary resuscitation in nursing homes

811

CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY

812

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study

813

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study

814

Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey

815

Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,

816

Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance

817

cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)

818

Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article

819

Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis

820

Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists

821

Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?

822

Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.

823

Cardiopulmonary resuscitation: Historical perspective to recent investigations

824

Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India

825

Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study

826

Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study

827

Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats

828

Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure

829

Cardiorenal Effects of Recombinant Human Natriuretic Peptides

830

Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article

831

Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure

832

Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.

833

Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats

834

Cardiorenal Syndrome

835

Cardiorenal syndrome

836

Cardiorenal Syndrome Review Article

837

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

838

Cardiorenal Syndrome or Renocardiac Syndrome

839

Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure

840

Cardio-renal-anemia syndrome: a report of three cases

841

Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study

842

Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs

843

Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses

844

Cardiorespiratory challenges in Rettʹs syndrome

845

Cardiorespiratory changes during upper gastrointestinal endoscopy

846

Cardio-respiratory control during early development in the model animal zebrafish

847

Cardio-respiratory coupling in untreated patients with major depression

848

CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA

849

Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study

850

Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?

851

Cardiorespiratory fitness and coronary heart disease risk factor association in women

852

Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy

853

Cardiorespiratory Fitness and Metabolic Risk

854

Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review

855

Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension

856

Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study

857

Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention

858

Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template

859

Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents

860

Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study

861

Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)

862

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men

863

Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial

864

Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus

865

Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure

866

Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance

867

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

868

Cardiorespiratory responses to exercise after repair of the univentricular heart

869

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study

870

Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state

871

Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training

872

Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury

873

Cardioscopic guidance of linear lesion creation for radiofrequency ablation

874

Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis

875

CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects

876

CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy

877

Cardiosource is a good source for definition of trial acronyms

878

Cardiospermum halicacabum Linn.: Food and Drug

879

Cardiothoracic Surgeons Divided By a Common Language

880

Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox

881

Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement

882

Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3

883

Cardiothoracic surgery: a specialty in transition—good to great?

884

Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation

885

Cardiotocography and medicolegal issues

886

Cardiotocography in the Prognosis of Perinatal Outcome

887

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article

888

Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial

889

Cardiotocography Waveform Analysis Using Image Extraction Technique

890

Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass

891

Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots

892

Cardiotonic Drugs from the Avicenna's Point of View

893

Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine

894

Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats

895

Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats

896

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

897

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

898

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

899

Cardiotoxicity associated with sunitinib

900

Cardiotoxicity associated with sunitinib

901

Cardiotoxicity associated with sunitinib – Authorsʹ reply

902

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

903

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

904

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

905

Cardiotoxicity of 5-flourouracil: two case reports

906

Cardiotoxicity of cytotoxic drugs

907

Cardiotoxicity of Plants in Iran: a Review

908

Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)

909

Cardiotoxicity Research in Breast Cancer Patients: Past and Future

910

Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised

911

Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience

912

Cardiotrophin-1 in Patients with Acute Myocardial Infarction

913

Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli

914

Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts

915

Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats

916

Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes

917

Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines

918

Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation

919

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy

920

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article

921

Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article

922

Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms

923

Cardiovascular Abnormalities in Hyperthyroidism

924

Cardiovascular abnormalities in hyperthyroidism

925

Cardiovascular Abnormalities in Hyperthyroidism

926

Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study

927

Cardiovascular abnormalities in never-treated hypertensives according to nondipper status

928

Cardiovascular Abnormalities in Sickle Cell Disease

929

Cardiovascular activity and the antibody response to vaccination

930

Cardiovascular adaptations to endurance training and detraining in young and older athletes

931

Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly

932

Cardiovascular Aging: What We Can Learn From Caloric Restriction

933

Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)

934

Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats

935

Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade

936

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

937

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

938

Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus

939

Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

940

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep

941

Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?

942

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

943

Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)

944

Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization

945

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

946

Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency

947

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

948

Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial

949

Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension

950

Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture

951

Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study

952

Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran

953

Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers

954

Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer

955

Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes

956

Cardiovascular anomalies associated with chromosome 22q11.2 deletion

957

Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome

958

Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study

959

Cardiovascular applications for artifical structural proteins produced by recombinant technologies

960

Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS

961

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease

962

Cardiovascular autonomic function in healthy adolescents

963

Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease

964

Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria

965

Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats

966

Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age

967

Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey

968

Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice

969

Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes

970

Cardiovascular benefits of nuts

971

Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011

972

Cardiovascular cavitation

973

Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery

974

Cardiovascular changes in response to ovarian stimulation

975

Cardiovascular Characteristics in American Youth With Prehypertension

976

Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)

977

Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient

978

Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran

979

Cardiovascular Complications in Obstructive Sleep Apnea Syndrome

980

Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation

981

Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management

982

Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article

983

Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience

984

Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old

985

Cardiovascular complications of malignant carcinoid disease, ,

986

Cardiovascular Complications of Radiotherapy

987

Cardiovascular Complications of the Guillain-Barré Syndrome

988

Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning

989

Cardiovascular consequences of laparoscopic surgery

990

Cardiovascular consequences of sleep apnea: I -Epidemiology

991

Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms

992

Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment

993

Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review

994

Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture

995

Cardiovascular control in Antarctic fish

996

Cardiovascular data on sildenafil citrate: Introduction

997

Cardiovascular Death and Cancer Death—Competing Risk?

998

Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature

999

Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study

1000

Cardiovascular disease

بازگشت